Literature DB >> 20009120

[Mastocytosis--diagnostic criteria and treatment].

Izabela Dereń-Wagemann1, Małgorzata Kuliszkiewicz-Janus, Kazimierz Kuliczkowski.   

Abstract

Mastocytosis is a heterogeneous group of rare diseases characterized by the proliferation and accumulation of mast cells in one or more organs such as the skin, bone marrow, liver, spleen, and lymph nodes. According to the WHO classification, mastocytosis is divided into seven subvariants. The symptoms are associated with mediator release and impaired organ function due to infiltration by neoplastic mast cells. There is a higher risk of anaphylactic shock; therefore education of the patients is very important. Patients may be asymptomatic. Symptomatic treatment is used in cutaneous mastocytosis and in indolent systemic mastocytosis. More aggressive subvariants of mastocytosis are treated with chemotherapy, targeted therapy, and bone marrow transplantation.

Entities:  

Mesh:

Year:  2009        PMID: 20009120

Source DB:  PubMed          Journal:  Postepy Hig Med Dosw (Online)        ISSN: 0032-5449            Impact factor:   0.270


  2 in total

1.  Modulation of dermal equivalent of hypothalamus-pituitary-adrenal axis in mastocytosis.

Authors:  Jakub Antoniewicz; Bogusław Nedoszytko; Magdalena Lange; Justyna Wierzbicka; Magdalena Górska-Ponikowska; Marek Niedoszytko; Monika Zabłotna; Roman J Nowicki; Michał A Żmijewski
Journal:  Postepy Dermatol Alergol       Date:  2021-07-26       Impact factor: 1.837

2.  Assessing quality of life in patients with mastocytosis: development of the disease-specific questionnaire.

Authors:  Natalia Spolak-Bobryk; Marek Niedoszytko; Ewa Jassem; Marta Chełmińska; Magdalena Lange; Mikołaj Majkowicz; Bogusław Nedoszytko; Judyta Borchet
Journal:  Postepy Dermatol Alergol       Date:  2022-01-11       Impact factor: 1.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.